Targeted therapy with or without hormone therapy for prostate cancer that has spread a little
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests whether targeting the spots where cancer has returned with radiation or surgery, with or without hormone therapy, can help control prostate cancer that has come back in a few places after previous treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had radiation therapy for prostate cancer at least 2 years ago.
- Your cancer has come back in up to 5 spots, seen on scans like PSMA-PET or MRI.
- All spots where cancer has returned can be treated with radiation or surgery.
- Your PSA must have risen by a certain amount after your last radiation treatment.
- You have not had hormone therapy in the last 2 years or certain other treatments in the last 6 months.
- You are generally well enough to be up and about (ECOG score 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining standard hormone therapy and radiation with a special targeted radiation (PSMA-targeted radiotherapy) is safe and effective for men with high-risk prostate cancer that hasn't spread outside the pelvis.
This trial tests whether adding targeted radiation guided by a PET scan (along with hormone therapy) can improve outcomes for prostate cancer that has come back after surgery. The PET scan helps doctors look for spots outside the usual radiation area so treatment can be tailored.
This trial tests a new way of delivering radiation for prostate cancer that has come back after prostate surgery. It may help control the cancer by targeting the “prostate bed” area or nearby lymph nodes where it returned.
This Phase 3 trial tests whether treating only a small number of prostate cancer metastases can help people with “oligorecurrent” (limited repeat) prostate cancer. It may reduce cancer activity while avoiding broader whole-body treatment for some patients.
This trial tests the best way to treat prostate cancer that has come back after initial treatment (like surgery or radiation) and shows a few spots on a PSMA scan. It compares different salvage treatments, possibly including radiation and hormone therapy, to slow the cancer's growth.
This study tests whether adding a type of high-precision radiation (MDRT) to standard hormone therapy works better for men with prostate cancer that has spread to just a few places. It is for patients who are newly diagnosed and on long-term hormone therapy.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.